Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Florida
Pfizer
Jonsson Comprehensive Cancer Center
University of Nebraska
Cancer Research UK
Massive Bio, Inc.
Washington University School of Medicine
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Cedars-Sinai Medical Center
Celgene
CureOne
University of Texas Southwestern Medical Center
Stanford University
National Cancer Institute (NCI)